Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of General Physiology|October 28, 2015
Modal affinities of endplate acetylcholine receptors caused by loop C mutationsRidhima Vij, Prasad Purohit, Anthony Auerbach
The Journal of General Physiology|December 10, 2016
A mechanism for acetylcholine receptor gating based on structure, coupling, phi, and flipShaweta Gupta, Srirupa Chakraborty, Ridhima Vij, et al.
The Journal of General Physiology|January 13, 2019
Efficiency measures the conversion of agonist binding energy into receptor conformational changeTapan K Nayak, Ridhima Vij, Iva Bruhova, et al.
Frontiers in Medicine|January 8, 2024
Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trialConstanza de Dios, Ridhima Vij, Hosu Kim, et al.
Stem Cell Research & Therapy|March 4, 2022
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trialRidhima Vij, Kevin A Stebbings, Hosu Kim, et al.
Frontiers in Transplantation|July 12, 2024
Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case reportRidhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Stem Cell Research & Therapy|October 5, 2023
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access programRidhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Cytotherapy|October 19, 2024
Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access programRidhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Parkinson'S Disease|May 15, 2026
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical TrialRidhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Journal of Translational Autoimmunity|October 3, 2022
Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case reportRidhima Vij, Mallika Tripathy, Hosu Kim, et al.
Pageof 2